Odelo (Rivaroxaban)

Rivaroxaban, the active ingredient in Odelo, is an oral anticoagulant presented as a tablet for oral use. It is used to prevent and treat blood clots in conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. GNH USA supplies Odelo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Odelo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Rivaroxaban is an anticoagulant that works on the coagulation cascade — its clinical use focuses on preventing and treating thromboembolic disorders.

- Atrial fibrillation: reduces the risk of stroke and systemic embolism in patients with non‑valvular atrial fibrillation. - Deep vein thrombosis (DVT) treatment: helps resolve existing clot burden and prevents extension. - Pulmonary embolism (PE) treatment: facilitates clot resolution and reduces recurrence risk. - DVT prophylaxis after orthopedic surgery: lowers incidence of postoperative venous thromboembolism. - Stroke prevention : prevents recurrent stroke in patients with prior ischemic stroke linked to atrial fibrillation. - Cardiovascular    ​  

The     … ​ … … ....   t ​ .... ... ...

​